A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer - Concepedia

Concepedia

Publication | Open Access

A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer

DOI Full Paper Access

27

Citations

18

References

2011

Year

Gordon Rustin, Nicholas Reed, Gordon C. Jayson, Jonathan A. Ledermann, Malcolm Adams, Timothy Perren, Christopher Poole, M. Lind, Mojca Persic, Sharadah Essapen,

Annals of Oncology

Phase Ii TrialMedicinePharmacologyClinical TrialsGynecologyNovel EpothilonePharmacotherapyPlatinum-resistant Ovarian CancerCancer TreatmentOncologyGynecology OncologyEndocrine-related CancerOvarian Cancer

References

	Year	Citations

Page 1

Page 1